Imaging BiometricsIQAIF PS Ratio is 5.00 as of Jul. 13, 2026, which is 50% below its 10-year median of 10.00. The stock has 3 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Imaging Biometrics ranks worse than 74.2% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Imaging Biometrics's share price is $0.02.
Imaging Biometrics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Hence, Imaging Biometrics's PS Ratio for today is 5.00.
The historical rank and industry rank for Imaging Biometrics's PS Ratio or its related term are showing as below:
IQAIF'
s PS Ratio Range Over the Past 10 Years
Min: 1.5 Med: 10 Max: 72.5
Current: 3.5
During the past 13 years, Imaging Biometrics's highest PS Ratio was 72.50. The lowest was 1.50. And the median was 10.00.
IQAIF's PS Ratio is ranked worse than 74.2% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs IQAIF: 3.50
Imaging Biometrics Ltd revenue growth has slowed down over the past 12 months.
During the past 5 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 13 years, Imaging Biometrics's highest 3-Year average Revenue per Share Growth Rate was 61.10% per year. The lowest was -87.90% per year. And the median was 0.25% per year.
Back to Basics: PS Ratio
Imaging Biometrics (OTCPK:IQAIF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Imaging Biometrics PS Ratio Related Terms
Imaging Biometrics PS Ratio Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Imaging Biometrics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Biometrics PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's PS Ratio distribution charts can be found below:
* The bar in red indicates where Imaging Biometrics's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Imaging Biometrics's Share Price of today is $0.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imaging Biometrics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Imaging Biometrics (IQAIF) has a PS Ratio of 5.00 as of Jul. 13, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Imaging Biometrics and its competitors. This is 50% below median its historical median of 10.00. Over the past decade, Imaging Biometrics' PS Ratio has ranged from 1.50 to 72.50. According to the industry distribution chart, Imaging Biometrics ranks #489 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 74.2%.
Is Imaging Biometrics' PS Ratio too high?
Imaging Biometrics' current PS Ratio of 5.00 is 50% below median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 72.50. The Healthcare Providers & Services industry median PS Ratio is 1.47. Imaging Biometrics' value of 5.00 is 240.1% above this industry median. Based on the distribution chart, Imaging Biometrics ranks #489 out of 659 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Imaging Biometrics' PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #489 out of 659 companies for PS Ratio. This places Imaging Biometrics in the lower half of its industry. The industry median PS Ratio is 1.47. Imaging Biometrics' value of 5.00 is 240.1% above this benchmark. Historically, Imaging Biometrics' own PS Ratio has ranged from 1.50 to 72.50 over the past decade. While the company's 10-year median is 10.00 vs. the industry median of 1.47, Imaging Biometrics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current PS Ratio of 5.00 is 240.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current PS Ratio is 5.00, which is 50% below median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current PS Ratio of 5.00. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current PS Ratio is 5.00, which is 50% below median its 10-year median of 10.00 and 240.1% above the Healthcare Providers & Services industry median of 1.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current PS Ratio is 5.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 